Direct and Indirect anti-inflammatory effects of tulathromycin in bovine macrophages: Inhibition of CXCL-8 secretion, induction of apoptosis, and promotion of efferocytosis

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1385-1393

  Fischer, Carrie D ^a   Beatty, Jennifer K ^a   Duquette, Stephanie C ^a   Morck, Douglas W ^a   Lucas, Merlyn J ^b   Buret, André G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TULATHROMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CALF (BOVINE); CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; MANNHEIMIA HAEMOLYTICA; MONOCYTE; NEUTROPHIL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CASPASE 3; CATTLE; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DISACCHARIDES; GENE EXPRESSION REGULATION; HETEROCYCLIC COMPOUNDS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MANNHEIMIA HAEMOLYTICA; NEUTROPHILS; OLIGOPEPTIDES; PHAGOCYTOSIS; PNEUMONIA OF CALVES, ENZOOTIC; SIGNAL TRANSDUCTION;

EID: 84874071226     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01598-12     Document Type: Article

References (54)

1. Murray PJ, Wynn TA. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11:723-737.
2. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. 1976. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science 192:1016 -1018.
3. Xu Y, Eissa NT. 2010. Autophagy in innate and adaptive immunity. Proc. Am. Thorac Soc. 7:22-28.
4. Savill J, Dransfield I, Gregory C, Haslett C. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965-975.
5. Cohen JJ. 1991. Programmed cell death in the immune system. Adv. Immunol. 50:55- 85.
6. Han H, Iwanaga T, Uchiyama Y, Fujita T. 1993. Aggregation of macrophages in the tips of intestinal villi in guinea pigs: their possible role in the phagocytosis of effete epithelial cells. Cell Tissue Res. 271:407- 416.
7. Hopkinson-Woolley J, Hughes D, Gordon S, Martin P. 1994. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J. Cell Sci. 107(Part 5):1159 -1167.
8. Maianski NA, Maianski AN, Kuijpers TW, Roos D. 2004. Apoptosis of neutrophils. Acta Haematol. 111:56-66.
9. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. 1996. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157:2577-2585.
10. Cao C, Lawrence DA, Strickland DK, Zhang L. 2005. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood 106:3234 -3241.
11. Janssen WJ, Barthel L, Muldrow A, Oberley-Deegan RE, Kearns MT, Jakubzick C, Henson PM. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 184:547-560.
12. Kolaczkowska E, Koziol A, Plytycz B, Arnold B. 2010. Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis. Immunobiology 215:492-504.
13. Huynh ML, Fadok VA, Henson PM. 2002. Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41-50.
14. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. 1997. Immunosuppressive effects of apoptotic cells. Nature 390:350 -351.
15. Clinkenbeard KD, Clarke CR, Hague CM, Clinkenbeard P, Srikumaran S, Morton RJ. 1994. Pasteurella haemolytica leukotoxin-induced synthesis of eicosanoids by bovine neutrophils in vitro. J. Leukoc. Biol. 56:644-649.
16. Henricks PA, Binkhorst GJ, Drijver AA, Nijkamp FP. 1992. Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes. Infect. Immun. 60:3238 -3243.
17. Shewen PE, Wilkie BN. 1982. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect. Immun. 35:91-94.
18. Walker RD, Hopkins FM, Schultz TW, McCracken MD, Moore RN. 1985. Changes in leukocyte populations in pulmonary lavage fluids of calves after inhalation of Pasteurella haemolytica. Am. J. Vet. Res. 46: 2429-2433.
19. Buret AG. 2010. Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin. Can. J. Vet. Res. 74:1-10.
20. Hsuan SL, Kannan MS, Jeyaseelan S, Prakash YS, Malazdrewich C, Abrahamsen MS, Sieck GC, Maheswaran SK. 1999. Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-kappaB activation and calcium elevation. Microb. Pathog. 26:263-273.
21. Singh K, Ritchey JW, Confer AW. 2011. Mannheimia haemolytica: bacterial- host interactions in bovine pneumonia. Vet. Pathol. 48:338 -348.
22. Ichikawa Y, Ninomiya H, Koga H, Tanaka M, Kinoshita M, Tokunaga N, Yano T, Oizumi K. 1992. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am. Rev. Respir. Dis. 146:196 -203.
23. Lee WD, Flynn AN, LeBlanc JM, Merrill JK, Dick P, Morck DW, Buret AG. 2004. Tilmicosin-induced bovine neutrophil apoptosis is cell-specific and downregulates spontaneous LTB4 synthesis without increasing Fas expression. Vet. Res. 35:213-224.
24. Mikasa K, Kita E, Sawaki M, Kunimatsu M, Hamada K, Konishi M, Kashiba S, Narita N. 1992. The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice. J. Antimicrob. Chemother. 30: 339-348.
25. Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y. 1989. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp. Clin. Res. 15:527-533.
26. Tsuchihashi Y, Oishi K, Yoshimine H, Suzuki S, Kumatori A, Sunazuka T, Omura S, Matsushima K, Nagatake T. 2002. Fourteen-member macrolides suppress interleukin-8 production but do not promote apoptosis of activated neutrophils. Antimicrob. Agents Chemother. 46:1101-1104.
27. Aoshiba K, Nagai A, Konno K. 1995. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob. Agents Chemother. 39: 872-877.
28. Chin AC, Lee WD, Murrin KA, Morck DW, Merrill JK, Dick P, Buret AG. 2000. Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages. Antimicrob. Agents Chemother. 44:2465-2470.
29. Chin AC, Morck DW, Merrill JK, Ceri H, Olson ME, Read RR, Dick P, Buret AG. 1998. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs. Am. J. Vet. Res. 59:765-771.
30. Fischer CD, Beatty JK, Zvaigzne CG, Morck DW, Lucas MJ, Buret AG. 2011. Anti-inflammatory benefits of antibiotic-induced neutrophil apoptosis: tulathromycin induces caspase-3-dependent neutrophil programmed cell death and inhibits NF-kappaB signaling and CXCL8 transcription. Antimicrob. Agents Chemother. 55:338 -348.
31. Shuster DE, Kehrli ME Jr, Rainard P, Paape M. 1997. Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli. Infect. Immun. 65: 3286-3292.
32. Duffin R, Leitch AE, Fox S, Haslett C, Rossi AG. 2010. Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol. Rev. 236:28-40.
33. Crawford ED, Wells JA. 2011. Caspase substrates and cellular remodeling. Annu. Rev. Biochem. 80:1055-1087.
34. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. 2011. Immunomodulatory effects of macrolide antibiotics-part 1: biological mechanisms. Respiration 81:67-74.
35. Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, Hellewell PG, Whyte MK. 2003. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J. Immunol. 171:5380 -5388.
36. Singh K, Confer AW, Hope JC, Rizzi T, Wyckoff JH III, Weng HY, Ritchey JW. 2011. Cytotoxicity and cytokine production by bovine alveolar macrophages challenged with wild type and leukotoxin-deficient Mannheimia haemolytica. Vet. J. 188:221-227.
37. Singh K, Confer AW, Step DL, Rizzi T, Wyckoff JH, III, Weng HY, Ritchey JW. 2012. Cytokine expression by pulmonary leukocytes from calves challenged with wild-type and leukotoxin-deficient Mannheimia haemolytica. Vet. J. 192:112-119.
38. Ravichandran KS. 2011. Beginnings of a good apoptotic meal: the findme and eat-me signaling pathways. Immunity 35:445- 455.
39. Hart SP, Dransfield I, Rossi AG. 2008. Phagocytosis of apoptotic cells. Methods 44:280 -285.
40. Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M, Reynolds PN. 2006. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur. Respir. J. 28:486-495.
41. Marriott HM, Hellewell PG, Cross SS, Ince PG, Whyte MK, Dockrell DH. 2006. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia. J. Immunol. 177:6480-6488.
42. Murphy BS, Sundareshan V, Cory TJ, Hayes D Jr, Anstead MI, Feola DJ. 2008. Azithromycin alters macrophage phenotype. J. Antimicrob. Chemother. 61:554 -560.
43. Vrancic M, Banjanac M, Nujic K, Bosnar M, Murati T, Munic V, Polancec DS, Belamaric D, Parnham MJ, Haber VE. 2012. Azithromycin distinctively modulates classical activation of human monocytes in vitro. Br. J. Pharmacol. 165:1348 -1360.
44. Yamaryo T, Oishi K, Yoshimine H, Tsuchihashi Y, Matsushima K, Nagatake T. 2003. Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob. Agents Chemother. 47:48 -53.
45. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21:325-332.
46. Leiva M, Ruiz-Bravo A, Jimenez-Valera M. 2008. Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation. Chest 134:20 -29.
47. Dockrell DH, Lee M, Lynch DH, Read RC. 2001. Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J. Infect. Dis. 184:713-722.
48. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol. 161:2636 -2641.
49. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, Kornfeld H. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298- 304.
50. Barkett M, Xue D, Horvitz HR, Gilmore TD. 1997. Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272:29419 -29422.
51. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. 1999. Apoptosis overrides survival signals through a caspase-mediated dominantnegative NF-kappa B loop. Nat. Cell Biol. 1:227-233.
52. Reuther JY, Baldwin AS Jr. 1999. Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J. Biol. Chem. 274:20664 -20670.
53. Ichiyama T, Nishikawa M, Yoshitomi T, Hasegawa S, Matsubara T, Hayashi T, Furukawa S. 2001. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob. Agents Chemother. 45:44-47.
54. Goubau S, Morck DW, Buret A. 2000. Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica. Can. J. Vet. Res. 64:238 -242.